Increased awareness about diabetes is leading to more usage of glucose detection methods and devices, eventually expanding the global market of medical biosensors. Moreover the increasing use of medical biosensors in home diagnostics and in research oriented hospitals and laboratories, are resulting in strong market growth. The global medical biosensors market is changing towards becoming more commercially viable in the industry, with its various advanced range of technologically adopted products. The global medical biosensors market is expected to grow.

Integration of various healthcare techniques and the affordability of this technology are key driving factors. However rapid obsolescence of devices is proving to be a challenge for market growth.

This report has been prepared based on an in-depth study of the market along with inputs from various experts. The report contains market and vendor landscape supported by drivers, restraints and trends. The report covers the current and future market for global medical biosensors. The report also profiles key vendors in the field of medical biosensors.

TABLE OF CONTENTS

01. Executive Summary
02. Introduction
03. Market Landscape
04. Vendor Landscape
05. Market Growth Drivers
06. Market Challenges
07. Market Trends
08. Key Vendor Analysis
08.1 Universal Biosensors Inc.
08.2 Nova Biomedical Corp.
08.3 Abbott Laboratories
08.4 Bayer AG
08.5 Lifescan Inc.
09. Other Reports in this Series

List of Exhibits                                     

Exhibit 1: Global Medical Biosensors Market 2010-2014 (US $ Billion)
Exhibit 2:  Estimated Percentage Share of Different Segments in the Global Medical Biosensors market by 2014
Exhibit 3: Geographic Segmentation
Exhibit 4: Vendor Segmentation